Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.

Immunoprecipitation

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HLA tapasin independence: broader peptide repertoire and HIV control.

Proceedings of the National Academy of Sciences of the United States of America·2020

Same author

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup>+</sup> T Cells in COVID-19.

Cell·2020

Same author

Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5.

Immunology·2020

Same author

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

Cell·2020

Same author

Interferon-γ Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

Same author

Cross-reactive memory T cells and herd immunity to SARS-CoV-2.

Nature reviews. Immunology·2020

Same journal

The effect of glycyrrhetinic acid on pharmacokinetics of cortisone and its metabolite cortisol in rats.

Journal of biomedicine & biotechnology·2012

Same journal

Insights and hopes in umbilical cord blood stem cell transplantations.

Journal of biomedicine & biotechnology·2012

Same journal

Three-dimensional visualization with large data sets: a simulation of spreading cortical depression in human brain.

Journal of biomedicine & biotechnology·2012

Same journal

Bioconversion of sugarcane biomass into ethanol: an overview about composition, pretreatment methods, detoxification of hydrolysates, enzymatic saccharification, and ethanol fermentation.

Journal of biomedicine & biotechnology·2012

Same journal

Trends in tissue engineering for blood vessels.

Journal of biomedicine & biotechnology·2012

Same journal

Salinomycin as a drug for targeting human cancer stem cells.

Journal of biomedicine & biotechnology·2012

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

IMMUNOCAT-a data management system for epitope mapping studies.

Jo L Chung¹, Jian Sun, John Sidney

¹Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037, USA.

Journal of Biomedicine & Biotechnology

|May 22, 2010

Summary

This summary is machine-generated.

IMMUNOCAT is a new data management system that integrates clinical and experimental data for epitope discovery. This system facilitates rational vaccine design by enabling efficient analysis of immune recognition mechanisms.

More Related Videos

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Area of Science:

Immunology
Bioinformatics
Translational Research

Background:

Translational research linking molecular immunology to human clinical studies is crucial for rational vaccine design.
Managing and integrating diverse data from multiple sources presents a significant challenge in translational research.

Purpose of the Study:

To introduce IMMUNOCAT, an interactive data management system designed for epitope discovery research.
To demonstrate the utility of IMMUNOCAT in managing and analyzing integrated clinical and experimental data for allergy vaccine development.

Main Methods:

Established IMMUNOCAT, an interactive system for storing, querying, and analyzing clinical and experimental data.
Collected demographic, clinical (allergen skin tests, RAST), and laboratory data (T cell reactivity, MHC:peptide binding, HLA typing) from human donors.
Integrated diverse datasets within IMMUNOCAT for comprehensive analysis.

Main Results:

IMMUNOCAT successfully stores and integrates various data types, including clinical information, T cell assay results, MHC:peptide binding data, antibody titers, and HLA typing.
The system enables efficient querying and integrated analysis of complex datasets.
Demonstrated IMMUNOCAT's application in a large-scale project to identify allergen-specific T cell epitopes for vaccine design.

Conclusions:

IMMUNOCAT provides an efficient, systematic, and integrative approach to data management in translational epitope discovery research.
Bioinformatics and information management techniques, as exemplified by IMMUNOCAT, are vital for tracking and analyzing data in translational studies.
This system supports the rational design of allergy vaccines by facilitating epitope identification.